Esperanza Muela-Munoz
Sevilla, AN, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
Randomized clinical trial to evaluate the longitudinal HIV-1 reservoir and inflammation in treatment-naïve people starting dolutegravir/lamivudine versus dolutegravir plus tenofovir alafenamide/emtricitabine.
Journal: Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases
Published: January 09, 2025
Correction: Clinical, laboratory data and inflammatory biomarkers at baseline as early discharge predictors in hospitalized SARS-CoV-2 infected patients.
Journal: PloS one
Published: November 21, 2024
Mitochondrial Disorders After 12 Months of Human Immunodeficiency Virus Type 1 Preexposure Prophylaxis Based on Tenofovir Disoproxil Fumarate Plus Emtricitabine in Healthy Adults.
Journal: The Journal of infectious diseases
Published: September 17, 2024
Plasma concentrations of IL-6, MIP-1β, IP-10, and PTX-3 as predictors of the immunological response to antiretroviral treatment in people with HIV.
Journal: Frontiers in immunology
Published: June 12, 2024
HIV-1-DNA/RNA and immunometabolism in monocytes: contribution to the chronic immune activation and inflammation in people with HIV-1.
Journal: EBioMedicine
Published: May 08, 2024
Long-term effects on immunological, inflammatory markers, and HIV-1 reservoir after switching to a two-drug versus maintaining a three-drug regimen based on integrase inhibitors.
Journal: Frontiers in immunology
Published: April 26, 2024
HIV-1-specific T-cell responses and exhaustion profiles in people with HIV after switching to dual therapy vs. maintaining triple therapy based on integrase inhibitors.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: June 13, 2023
Decay kinetics of HIV-1-RNA in seminal plasma with dolutegravir/lamivudine versus dolutegravir plus emtricitabine/tenofovir alafenamide in treatment-naive people living with HIV.
Journal: The Journal of antimicrobial chemotherapy
Published: April 22, 2023
Response to: Reply to: Anti-CD4 autoantibodies in immunological nonresponder people living with HIV: cause of CD4+ T cell depletion?
Journal: AIDS (London, England)
Published: January 25, 2023
Humoral and cellular immunity to SARS-COV-2 after vaccination with mRNA vaccines in PLWH with discordant immune response. Influence of the vaccine administered.
Journal: Frontiers in immunology
Published: December 22, 2022
Anti-CD4 autoantibodies in immunological nonresponder people with HIV: cause of CD4 + T-cell depletion?
Journal: AIDS (London, England)
Published: May 24, 2022
Clinical, laboratory data and inflammatory biomarkers at baseline as early discharge predictors in hospitalized SARS-CoV-2 infected patients.
Journal: PloS one
Published: March 02, 2022
Last Updated: 09/26/2026